title: Cerebral vein thrombosis and lupus anticoagulant antibodies.
authors.forename: M
authors.initials: M
authors.lastname: Marietta
authors.forename: M
authors.initials: M
authors.lastname: Bertesi
authors.forename: L
authors.initials: L
authors.lastname: Simoni
authors.forename: I
authors.initials: I
authors.lastname: Castelli
authors.forename: C
authors.initials: C
authors.lastname: Cappi
authors.forename: G
authors.initials: G
authors.lastname: Torelli
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000188:drug therapy / Q000209:etiology*; D001327:Autoimmune Diseases / Q000150:complications / Q000276:immunology; D017984:Enoxaparin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000502:physiology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000276:immunology; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000209:etiology; D020225:Sagittal Sinus Thrombosis / Q000188:drug therapy / Q000209:etiology*; D013924:Thrombophlebitis / Q000188:drug therapy / Q000209:etiology; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D016682:Lupus Coagulation Inhibitor; D014859:Warfarin